Xilis

Xilis

  • 51-200 Employees
  • $19M Series A on 2022-07

Careers at Xilis


About Xilis

Xilis is a biotechnology company focused on revolutionizing precision oncology and cancer drug development. Utilizing their proprietary MicroOrganoSphere (MOS) technology and Precision Oncology Platform, Xilis is paving the way for personalized cancer treatment and accelerated drug discovery. The MOS technology involves microscale tumors that preserve the structure, genetic alterations, and immune microenvironment of individual patients, allowing for rapid diagnostics and personalized therapy prioritization. Xilis aims to guide oncologists in making timely treatment decisions to optimize therapeutic outcomes for patients, offering a cost-effective and high-throughput screening for drug candidates and providing diagnostic tools for personalized clinical trials.